Search Results for: About
Once again MenaQ7® is leading the efforts to validate the benefits of Vitamin K2 as MK-7 to support cardiovascular health. At the prestigious European Society of Cardiology Congress, PhD student from CARIM School for Cardiovascular Diseases at Maastricht University, Femke de Vries, presented an abstract from a post-hoc analysis of the previously published 1-year MenaQ7 … Continue reading New MenaQ7® Evidence Presented at the ESC Congress; further Solidifies Cardiovascular Benefits
Once again MenaQ7® is leading the efforts to validate the benefits of Vitamin K2 as MK-7 to support cardiovascular health. At the prestigious European Society of Cardiology Congress, PhD student from CARIM School for Cardiovascular Diseases at Maastricht University, Femke de Vries, presented an abstract from a post-hoc analysis of the previously published 1-year MenaQ7 cardiovascular study. The presentation sparked a lot of discussion about the publication of the post-hoc analysis expected later this year.
In the post-hoc analysis, the authors aimed to examine how supplementation of Vitamin K2 as MK-7 affected vascular stiffness in women going through pre-, peri-, and post-menopausal stages. The trial included 166 women (age 40-70 with low K2 status) who consumed 180 mcg MK-7 daily or placebo for one year.
Much-Needed Research on Heart Health in Women
Research on this specific demographic is critical. While cardiovascular disease has been considered a “man’s disease,” it is still the major cause of death in women over the age of 65, and research has been underrepresented.
The findings presented via the poster named “Beneficial Effects of One-Year Supplementation with Menaquinone-7 on Vascular Health and Blood Pressure in Post-Menopausal Women,” confirm a correlation between hormonal changes and their impact on the vasculature.
Post-menopausal women may experience heightened vascular stiffness, which can manifest as functional vascular damage. Arterial stiffness is a significant indicator of cardiovascular health, particularly in relation to blood pressure. Interestingly, it seems that enhancing one’s K2 status may positively influence both.
The abstract has been published in the European Heart Journal and is available on ESC 365, the cardiology knowledge hub. The post-hoc analysis will be published in a peer-reviewed journal later this year.
Get Your Science from the Source
At Gnosis, we are thrilled that our flag ship brand, MenaQ7, once again is leading the way in the validation of Vitamin K2 as MK-7’s critical role in supporting human health.
When it comes to formulating for heart health, we encourage you to get your science from the source and choose MenaQ7® Vitamin K2.
After this year’s A4M Spring Conference, Prof. Leon Schurgers sat with host Erika Schwartz, MD, to have an in-depth conversation about his research and how Vitamin K2 as MK-7 can be part of a holistic and integrative approach to health and well-being. Redefining Medicine is an intimate and personalized program that shows a different side … Continue reading Prof Leon Schurgers on A4M Redefining Medicine Podcast
After this year’s A4M Spring Conference, Prof. Leon Schurgers sat with host Erika Schwartz, MD, to have an in-depth conversation about his research and how Vitamin K2 as MK-7 can be part of a holistic and integrative approach to health and well-being.
Redefining Medicine is an intimate and personalized program that shows a different side of the practice of medicine. The conversation with Prof. Leon Schurgers did not fail to deliver.
Enjoy the podcast to learn how Prof. Schurgers work began with vitamin K, the facts that have been elucidated during his illustrious career, as well as a view of how he, as a researcher, works closely with clinicians at Maastricht University.
> Watch the Podcast
The global concern surrounding cardiovascular health continues to grow, prompting many of us to explore the supportive benefits offered by dietary supplementation. In recent years, researchers have placed a significant emphasis on understanding the role of arterial stiffness in cardiovascular health. Additionally, they have made groundbreaking discoveries regarding the vitamin K-dependent protein Matrix Gla Protein … Continue reading The Significance of Prioritizing Heart Health and the Impact of MenaQ7® Vitamin K2
The global concern surrounding cardiovascular health continues to grow, prompting many of us to explore the supportive benefits offered by dietary supplementation. In recent years, researchers have placed a significant emphasis on understanding the role of arterial stiffness in cardiovascular health. Additionally, they have made groundbreaking discoveries regarding the vitamin K-dependent protein Matrix Gla Protein (MGP). Through its many clinical trials, MenaQ7® is the vitamin K2 brand shown to effectively activate this critical cardio-supporting protein.
Vitamin K2 and Matrix Gla Protein (MGP)
Matrix Gla Protein (MGP) stands out as the most powerful prohibitor of vascular calcification, provided that the body has sufficient Vitamin K2 to activate it. Unfortunately, with vitamin K2 being almost completely void from typical Western diets, it is no wonder most people have deficient or insufficient levels of vitamin K2.
The Clinically Proven Vitamin K2 as MK-7 for Heart Health
Enter MenaQ7®: the clinically proven Vitamin K2 as MK-7. Our pioneering studies – randomized, double-blind, placebo-controlled trials – have demonstrated the remarkable benefits of MenaQ7®. One groundbreaking study, over the course of three years, showed that daily consumption of a nutritional dose of 180 mcg of MenaQ7® inhibited age-related arterial stiffening and improved arterial elasticity — a key aspect of maintaining a healthy cardiovascular system.
By choosing MenaQ7® for your supplement brand, be assured your ingredient is backed by scientific evidence confirming it supports robust heart health.
Learn more about the power of MenaQ7® and how the essence of this ingredient meets the top selection criteria of supplement buyers: Proof that it works!
> Download Brochure
For athletes, optimizing performance and maintaining peak health is of great importance. While protein powders have long been the go-to supplement for muscle recovery and growth, the incorporation of additional key nutrients can unlock further benefits. One such valuable addition is MenaQ7® Vitamin K2, which offers clinically proven health benefits for bone and cardiovascular health … Continue reading Unveiling the Benefits of MenaQ7® Vitamin K2 in Sports and Protein Powders
For athletes, optimizing performance and maintaining peak health is of great importance. While protein powders have long been the go-to supplement for muscle recovery and growth, the incorporation of additional key nutrients can unlock further benefits. One such valuable addition is MenaQ7® Vitamin K2, which offers clinically proven health benefits for bone and cardiovascular health – key areas for sports and fitness enthusiasts, as well as for the weekend warrior that seeks to stay active for longer.
Strong, resilient bones are crucial for athletes to withstand the demands of challenging training, and although cardiovascular health is perhaps not the first thing that comes to mind in relation to sports performance, it plays a pivotal role in our foundational health and our overall fitness.
Today, consumers are increasingly focused on the validation of claimed benefits when purchasing supplements and functional foods. The demand for effective and clinically proven ingredients has never been higher. With MenaQ7®, you can confidently state its benefits as it is the only clinically proven Vitamin K2 as MK-7 for bone and heart health available in the market to date. Furthermore, preliminary data from recent research on MenaQ7® demonstrates its ability to counteract oxidative stress in smooth muscle cells and increase ATP production, revealing its potential for additional benefits.
To learn more about how incorporating MenaQ7® can diversify and add value to your sports portfolio, we invite you to download our brochure. The brochure includes a step-by-step guide on best practices for formulating vitamin K2 in protein powders, providing you with the best starting point for success.
> Download Your Step-By-Step Guide
Creating the Vitamin K2 category almost 20 years ago, a new MenaQ7® brand identity earmarks the next era of K2. Gnosis by Lesaffre is excited to announce the new identity for its uniquely scientifically backed Vitamin K2 as MK-7: MenaQ7®â. The established K2 category creator with more than 22+ published human clinical trials, MenaQ7® as … Continue reading Experience the New MenaQ7 K2 Brand Identity
Creating the Vitamin K2 category almost 20 years ago, a new MenaQ7® brand identity earmarks the next era of K2.
Gnosis by Lesaffre is excited to announce the new identity for its uniquely scientifically backed Vitamin K2 as MK-7: MenaQ7®â. The established K2 category creator with more than 22+ published human clinical trials, MenaQ7® as a brand has remained relatively unchanged for the past 14 years, with a keen focus on validated benefits for bone health in children and adults and cardiovascular health in adults. But in acquiring MenaQ7® in 2021, Gnosis recognized the growing potential of Vitamin K2 for more areas of health, marking the perfect time to introduce the new MenaQ7® Natural Vitamin K2 as MK-7.
“The foundation of clinical evidence using MenaQ7® is what built the Vitamin K2 category and shaped our understanding of this important nutrient as we know it today. We believe the brand has signified ‘Quality Confirmed by Science,’ which is why so many of our partners include the logo on their product labels, marketing collateral, and websites,” says Marc Philouze, Gnosis by Lesaffre General Manager. “Yet research is beckoning the continuation of that pioneering spirit, and more work must be done to confirm Vitamin K2’s expanding role in supporting other areas of health. To that end, we have decided to introduce a new logo and brand identity for this new journey.”
New Elements
Customers and the industry can expect no change in the core tenants of MenaQ7®: Science, Expertise, and Support. These pillars will anchor the brand on this new path of innovation, according to Philouze, which led to the “magnifying glass” component of the logo.
“The magnifying glass speaks to the curious spirit of discovery, and that quality and science must be meticulously sought,” he continues. “Curiosity is essential to usher Vitamin K2 into the future – illuminating new indications with technological innovations unlocking new consumer applications.”
Other new elements are the logo’s colors and tagline. The new logo emphasizes Gnosis’s dedication to natural processes that leave minimal environmental impact. To that end, the colors are softened and reversed from the traditional dark blue with a light green accent. And where MenaQ7® has long been “Vitamin K2 as MK-7,” the MenaQ7 logo tagline is now “Natural Vitamin K2 as MK-7.”
“The visual identity introduced today has been designed to better connect with our customers and the industry, and represent the work we do, utilizing what nature has to offer and the protection of our planet’s resources,” concludes Philouze. “As we look to the future, we see nothing but promise and potential, particularly as the benefits of Vitamin K2 are expanding. Here, again, we will lead in that discovery with MenaQ7®.”
The new brand identity is reflected on the refreshed www.MenaQ7.com and will make the transition to quality finished products featuring MenaQ7®.
>_______
About Gnosis by Lesaffre
Gnosis by Lesaffre harnesses the power of microorganisms and biotransformation processes like fermentation to cultivate nutritional actives, probiotics, and nutritional and functional yeasts that benefit human health and well-being. The team draws on its focused research and application capabilities to collaborate with nutraceutical and pharmaceutical brands to develop game-changing products for their customers.
Gnosis by Lesaffre – Exploring Life to Improve Living. http://www.GnosisByLesaffre.com
About Lesaffre
A key global player in fermentation for more than a century, Lesaffre, with a 2.2-billion-euro turnover, and established on all continents, counts 10,700 employees and more than 70 nationalities. On the strength of this experience and diversity, we work with customers, partners, and researchers to find ever more relevant answers to the needs of food, health, naturalness, and respect for our environment. Thus, every day, we explore and reveal the infinite potential of microorganisms. To nourish 10 billion people, in a healthy way, in 2050 by making the most of our planet’s resources is a major and unprecedented issue. We believe fermentation is one of the most promising answers to this challenge.
Lesaffre – Working together to better nourish and protect the planet.
Gnosis enriches its research advisory board to reflect existing clinical partnerships exploring new indications, advancing the potential for the K2 category. Gnosis by Lesaffre, the leading K2 supplier with the most and best clinically validated Vitamin K2 as MK-7, MenaQ7®, has enjoyed long-standing relationships with the world’s most renowned researchers. Today, the company announces … Continue reading Gnosis Expands Long-Standing Vitamin K2 Scientific Advisory Committee
Gnosis enriches its research advisory board to reflect existing clinical partnerships exploring new indications, advancing the potential for the K2 category.
Gnosis by Lesaffre, the leading K2 supplier with the most and best clinically validated Vitamin K2 as MK-7, MenaQ7®, has enjoyed long-standing relationships with the world’s most renowned researchers. Today, the company announces it is enhancing its Scientific Advisory Committee to highlight its commitment to exploring new indications while also identifying an expanding global presence of top thought leaders in biomedical research focused on Vitamin K2.
The Vitamin K2 Scientific Advisory Committee plays an integral role in program conceptualization, strategic development, and scientific advisory research regarding Vitamin K2. This group of esteemed, independent experts represents diverse geographic origins, helping Gnosis to identify specific population needs across the globe, offering a wide range of expertise and unique perspectives around K2. This, in turn, will return more robust opportunities for our finished product partners to create more impactful products for the market.
The Committee is chaired by the undisputed expert in Vitamin K2 research, Dr. Leon Schurgers, a Full Professor of Biochemistry of Vascular Calcification, Vice-Chair of Biochemistry at the Cardiovascular Research Institute Maastricht (CARIM), and chair of the stem cell research university Maastricht (SCRUM), Maastricht University (the Netherlands). He is also scientific advisor of the steering scientific board on the worldwide quality assurance plan for vitamin K detection, a member of the scientific advisory board of the Dutch Thrombosis Society, and author of more than 240 research papers in the international scientific press.
The Gnosis Vitamin K2 Scientific Advisory Committee was established based on the long-term, historical collaboration between Dr. Schurgers and Gnosis (previously NattoPharma). “No one has been a bigger proponent elucidating the benefits of vitamin K, and in particular K2 than Dr. Schurgers, as well as citing the absolute need for a K2-specific recommended daily intake (RDI),” says Jean-Francois Jeanne, Substantiation & Applications Team Manager. “Further, Gnosis has supported Research Teams worldwide, which has led to many new insights from clinical studies, including those identifying new clinical indications for K2, and combinations for K2, such as NOACs or Omega-3. This has ushered in an increased awareness of Vitamin K2’s potential grounded in science.”
“The collaboration between Gnosis and our research group at Maastricht University has led to many ground- breaking studies, including two PhD students that have defended their work at Maastricht University,” Schurgers says. “Further, Gnosis (previously NattoPharma) was a partner in EU Horizon 2020 innovative training programs, in which Maastricht University was beneficiary or coordinator. This clearly shows the scientific commitment of Gnosis.”
The Members of the Committee include:
• Hogne Vik, MD, PhD, MBA: A physician by education, Dr. Vik has served as a clinician, researcher, and Professor in Medicine at the University of Bergen, Norway. He is the author of more than 100 international research papers and has the last 25 years especially been interested in exploring health benefits associated with regular intake of vitamin K2 and omega-3 fatty acids. He has a successful scientific and commercial track record around these substances both within the pharmaceutical and dietary supplement industries. As previous CEO and Chief Medical Officer with NattoPharma ASA, he now serves as a medical and scientific advisor at Gnosis by Lesaffre.
• Katarzyna Maresz, PhD: Vitamin K2 scientific expert, Dr. Maresz is the former President of the International Science and Health Foundation, an independent research consortium dedicated to educating about the clinically validated benefits of nutrients, and the former Scientific Coordinator of the educational portal VitaminK2.org. She has published more than 30 scientific papers and is involved in Vitamin K2 clinical trials worldwide, cooperating with many research centers regarding the health effects and mechanism of action of Vitamin K2.
“I am honored to be invited into the Gnosis by Lesaffre Vitamin K2 Scientific Committee and look very much forward to continuing the scientific collaboration with Leon Schurgers and Katarzyna Maresz,” says Dr. Vik. “An assessment of available new biological data and documented clinical health benefits for vitamin K2 are, in my opinion, the best way to collect and communicate trustful information that will help people to understand why a regular intake of this vitamin is beneficial for health and quality of life.”
Gnosis by Lesaffre looks forward to announcing additional members in the immediate future. The group will be enlarged by those who have been collaborating with Gnosis for many years as well as new research partners to provide more visibility and ignite the passion for Vitamin K2.
“As the leader in the Vitamin K2 category, it is essential that we continue to drive the discovery of new indications and understanding, for benefit of our partners making the products that will shape a healthier global population,” says Marc Philouze, Gnosis by Lesaffre General Manager. “Our Scientific Advisory Committee has been at the forefront of that discovery, and their input will be essential to feed and continue in the delivery of the highest quality in science proposed by more than 70 Research & Application scientists working at Gnosis. It is our honor and obligation to enhance their potential for success.”
_______
About Gnosis by Lesaffre
Gnosis by Lesaffre harnesses the power of microorganisms and biotransformation processes like fermentation to cultivate nutritional actives, probiotics, and nutritional and functional yeasts that benefit human health and well-being. The team draws on its focused research and application capabilities to collaborate with nutraceutical and pharmaceutical brands to develop game-changing products for their customers.
About Lesaffre
A key global player in fermentation for more than a century, Lesaffre, with a 2.2 billion euro turnover, and established on all continents, counts 10,700 employees and more than 70 nationalities. On the strength of this experience and diversity, we work with customers, partners, and researchers to find ever more relevant answers to the needs of food, health, naturalness, and respect for our environment. Thus, every day, we explore and reveal the infinite potential of microorganisms. To nourish 10 billion people, in a healthy way, in 2050 by making the most of our planet’s resources is a major and unprecedented issue. We believe fermentation is one of the most promising answers to this challenge.
Lesaffre – Working together to better nourish and protect the planet.